Cystic Fibrosis (CF), 5T Allele Genotyping

CPT: 81224
Print Share

Test Details


  • 5T Allele Genotyping
  • Congenital Bilateral Absence of the Vas Deferens (CBAVD)


Detect congenital bilateral absence of the vas deferens (CBAVD) (OMIM 277180); refine the clinical impact of an identified R117H CF mutation


Routine screening for the 5T allele in the cystic fibrosis (CF) gene as part of standard CF carrier screening is not recommended since the goal of carrier screening is to identify couples at risk for having children with cystic fibrosis. The 5T allele is associated primarily with male infertility or atypical symptoms, although many individuals are asymptomatic. Analysis of the 5T allele may be a useful adjunct to the standard CF panel of 32 mutations (480533) in patients with male infertility or idiopathic pancreatitis. Genetic counseling is recommended for any person testing positive for the 5T variant.


Polymerase chain reaction (PCR) and a solution-phase multiplex allele-specific primer extension with subsequent hybridization to a bead array followed by fluorescence detection.

Specimen Requirements


Whole blood, amniotic fluid, chorionic villus sample (CVS) (submission of maternal blood is required for fetal testing), or LabCorp buccal swab kit (buccal swab collection kit contains instructions for use of a buccal swab)


7 mL whole blood, 10 mL amniotic fluid, 20 mg CVS, or LabCorp buccal swab kit

Minimum Volume

3 mL whole blood, 5 mL amniotic fluid, 10 mg CVS, or two buccal swabs


Lavender-top (EDTA) tube, yellow-top (ACD) tube, sterile plastic conical tube or two confluent T25 flasks for fetal testing, or LabCorp buccal swab kit

Storage Instructions

Maintain specimen at room temperature.

Causes for Rejection

Frozen specimen; hemolysis; quantity not sufficient for analysis; improper container; one buccal swab; wet buccal swab

Clinical Information

Special Instructions

Whole blood tube should be sent to the lab unopened. It is preferable not to perform additional testing on original tubes prior to PCR testing. A completed screening questionnaire must accompany specimens. Call 800-345-4363 to request forms, or photocopy the Cystic Fibrosis Screening Questionnaire from the Genetics Appendix online.


American College of Obstetricians and Gynecologists Committee on Genetics. ACOG Committee Opinion N° 486: Update on carrier screening for cystic fibrosis. Obstet Gynecol. 2011 Apr; 117(4):1028-1031. 21422883
Chillón M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995; 332(22):1475-1480. 7739684
Richards CS, Bradley LA, Amos J, et al. Standards and guidelines for CFTR mutation testing. Genet Med., 2002; 4(5):379-391; erratum: 2002; 4(6):471.12394352
Watson MS, Cutting GR, Desnick RJ, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med. 2004; 6(5):387-391; erratum: Genet Med. 2004; 6(6):548; Genet Med. 2005; 7(4):286.15371902


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
480970 5T Allele Genotyping 480978 5T Allele Genotyping 34729-4
480970 5T Allele Genotyping 480977 Comment: 77202-0
480970 5T Allele Genotyping 511938 PDF 51969-4

For Providers

Please login to order a test.


© 2018  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at Additional information regarding LOINC® codes can be found at, including the LOINC Manual, which can be downloaded at